86 results
Page 2 of 5
8-K
EX-1.1
ui5k a7ahz
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
424B5
c0h8x
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
iv8 05iok
28 Mar 22
Prospectus supplement for primary offering
4:53pm
8-K
EX-99.1
qs2f10z70fr
10 Nov 21
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results
4:16pm
8-K
EX-1.1
0sw9 i7jahkkw
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-99.1
knu d3zf0wfhwx
5 May 21
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results
4:01pm
8-K
j5chior
13 Nov 20
Termination of a Material Definitive Agreement
4:02pm
8-K
EX-1.1
rbw4p5pi
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm
424B5
fqpz4nv8otjp
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
kxi8hsi30s6i8
23 Jun 20
Prospectus supplement for primary offering
4:06pm